ANI PHARMACEUTICALS INC (ANIP)

Latest Insider Confidence Score

2026Q1

35.7
Bearish

Company insider confidence (by quarter)

2013Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Brown Robert E. JR 10% Owner 1,819,259 Aug 16, 2023
Meridian Venture Partners II Lp 10% Owner 1,819,259 Aug 16, 2023
Meridian Venture Partners II GP, L.P. 10% Owner 1,819,259 Aug 16, 2023
Meridian Venture Partners II, Co. 10% Owner 1,819,259 Aug 16, 2023
Shanmugam Muthusamy COO 995,620 Nov 20, 2023

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 5, 2026 Mar 5, 2026 CAREY STEPHEN P. CFO Sell 20.0 -7,312 -3.79% ✗ $552K
Mar 2, 2026 Mar 4, 2026 Mutz Christopher HEAD OF RARE DISEASE Sell 51.9 -417 -0.40% ✓ $30.9K
Mar 3, 2026 Mar 4, 2026 Gutwerg Ori SVP, GENERICS Sell 22.5 -2,060 -2.37% ✗ $157.6K
Mar 3, 2026 Mar 3, 2026 Walsh Patrick D Director Sell 20.0 -6,000 -10.27% ✗ $445.4K
Feb 26, 2026 Mar 2, 2026 Shanmugam Muthusamy COO Neutral 77.5 +11,116 2.11% ✗ -
Feb 26, 2026 Mar 2, 2026 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 91.3 +5,393 14.15% ✗ $46.4K
Feb 26, 2026 Mar 2, 2026 Mutz Christopher HEAD OF RARE DISEASE Sell 95.0 +19,085 22.50% ✗ $164.1K
Feb 26, 2026 Mar 2, 2026 Lalwani Nikhil CEO Sell 97.5 +63,375 17.67% ✗ $902.8K
Feb 26, 2026 Mar 2, 2026 Gutwerg Ori SVP, GENERICS Sell 95.0 +10,748 14.12% ✗ $164.1K
Feb 26, 2026 Mar 2, 2026 Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 87.5 +8,895 3.96% ✗ $164.1K
Feb 26, 2026 Mar 2, 2026 Davis Krista SVP, CHIEF HR OFFICER Sell 95.0 +9,255 18.79% ✗ $114.9K
Feb 26, 2026 Mar 2, 2026 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 95.0 +12,340 18.27% ✗ $114.9K
Feb 26, 2026 Mar 2, 2026 CAREY STEPHEN P. CFO Sell 95.0 +19,460 11.44% ✗ $204.9K
Feb 20, 2026 Feb 23, 2026 Mutz Christopher HEAD OF RARE DISEASE Sell 32.5 -5,323 -5.90% ✓ $415.3K
Feb 19, 2026 Feb 23, 2026 Davis Krista SVP, CHIEF HR OFFICER Sell 32.5 -3,814 -7.19% ✓ $296.5K
Feb 12, 2026 Feb 17, 2026 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 22.5 -1,051 -2.68% ✗ $80.9K
Feb 12, 2026 Feb 17, 2026 Mutz Christopher HEAD OF RARE DISEASE Sell 25.0 -12,608 -12.27% ✓ $967.6K
Feb 12, 2026 Feb 17, 2026 Lalwani Nikhil CEO Sell 17.5 -21,986 -5.78% ✗ $1.7M
Feb 12, 2026 Feb 17, 2026 Gutwerg Ori SVP, GENERICS Sell 20.0 -3,663 -4.59% ✗ $282.2K
Feb 12, 2026 Feb 17, 2026 Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 20.0 -3,325 -1.46% ✗ $256.2K
Feb 12, 2026 Feb 17, 2026 Davis Krista SVP, CHIEF HR OFFICER Sell 22.5 -2,470 -4.45% ✗ $190.3K
Feb 12, 2026 Feb 17, 2026 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 32.5 -3,813 -5.34% ✓ $293.7K
Feb 12, 2026 Feb 17, 2026 CAREY STEPHEN P. CFO Sell 20.0 -5,277 -3.01% ✗ $406.4K
Feb 11, 2026 Feb 13, 2026 CAREY STEPHEN P. CFO Sell 20.0 -5,503 -3.04% ✗ $419.6K
Feb 11, 2026 Feb 13, 2026 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 22.5 -3,011 -4.05% ✗ $229.6K
Feb 11, 2026 Feb 13, 2026 Davis Krista SVP, CHIEF HR OFFICER Sell 22.5 -3,017 -5.15% ✗ $230K
Feb 11, 2026 Feb 13, 2026 Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 20.0 -4,269 -1.84% ✗ $325.5K
Feb 11, 2026 Feb 13, 2026 Gutwerg Ori SVP, GENERICS Sell 20.0 -4,267 -5.08% ✗ $325.4K
Feb 11, 2026 Feb 13, 2026 Lalwani Nikhil CEO Sell 17.5 -30,659 -7.46% ✗ $2.3M
Feb 11, 2026 Feb 13, 2026 Mutz Christopher HEAD OF RARE DISEASE Sell 20.0 -4,546 -4.24% ✗ $346.6K
Feb 11, 2026 Feb 13, 2026 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 22.5 -1,762 -4.31% ✗ $134.4K
Feb 11, 2026 Feb 13, 2026 Shanmugam Muthusamy COO Sell 32.5 -2,898 -0.55% ✗ $221K
Jan 13, 2026 Jan 14, 2026 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 50.6 -500 -0.67% ✓ $42.2K
Dec 18, 2025 Dec 19, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 41.3 -1,622 -2.69% ✓ $133.7K
Dec 12, 2025 Dec 12, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.53% ✓ $32.9K
Dec 5, 2025 Dec 9, 2025 TANNENBAUM RENEE P Director Sell 22.5 -1,800 -6.68% ✗ $146.1K
Nov 13, 2025 Nov 17, 2025 Walsh Patrick D Director Sell 20.0 -11,643 -16.62% ✗ $750.9K
Nov 12, 2025 Nov 14, 2025 Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 17.5 -14,736 -5.97% ✗ $1.3M
Nov 13, 2025 Nov 14, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.53% ✓ $34.9K
Oct 13, 2025 Oct 14, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.53% ✓ $36K
Sep 19, 2025 Sep 22, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 45.0 -1,000 -1.63% ✓ $98K
Sep 12, 2025 Sep 15, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 22.5 -1,710 -2.72% ✗ $167.1K
Sep 12, 2025 Sep 15, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.52% ✓ $39.4K
Sep 3, 2025 Sep 4, 2025 Pera Antonio R Director Sell 20.0 -7,292 -24.35% ✗ $692.3K
Aug 25, 2025 Aug 26, 2025 Leonard Matthew J Director Sell 22.5 -2,528 -26.92% ✗ $229.1K
Aug 22, 2025 Aug 25, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 22.5 -1,763 -2.73% ✗ $160.6K
Aug 20, 2025 Aug 22, 2025 Shanmugam Muthusamy COO Sell 16.3 -100,000 -15.89% ✗ $9M
Aug 18, 2025 Aug 20, 2025 Thoma Jeanne Director Sell 17.5 -21,540 -47.93% ✗ $1.9M
Aug 20, 2025 Aug 20, 2025 Pera Antonio R Director Sell 20.0 -5,421 -15.33% ✗ $486.4K
Aug 18, 2025 Aug 18, 2025 Leonard Matthew J Director Sell 20.0 -6,937 -42.48% ✗ $611.6K
Aug 15, 2025 Aug 18, 2025 Walsh Patrick D Director Sell 20.0 -9,000 -11.39% ✗ $801.5K
Aug 14, 2025 Aug 18, 2025 Shanmugam Muthusamy COO Sell 16.3 -100,000 -13.71% ✗ $8.8M
Aug 15, 2025 Aug 18, 2025 Gassert Chad SVP - CORP. DEV. & STRATEGY Sell 17.5 -20,000 -7.50% ✗ $1.7M
Aug 12, 2025 Aug 14, 2025 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 20.0 -4,975 -10.87% ✗ $426.4K
Aug 12, 2025 Aug 14, 2025 Lalwani Nikhil CEO Sell 17.5 -56,960 -12.17% ✗ $4.9M
Aug 12, 2025 Aug 14, 2025 Gutwerg Ori SVP, GENERICS Sell 20.0 -5,873 -6.53% ✗ $508.2K
Aug 13, 2025 Aug 14, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.52% ✓ $35.5K
Aug 12, 2025 Aug 14, 2025 CAREY STEPHEN P. CFO Sell 17.5 -50,000 -21.66% ✗ $4.3M
Aug 12, 2025 Aug 14, 2025 HAUGHEY THOMAS Director Sell 17.5 -19,341 -34.62% ✗ $1.7M
Jul 18, 2025 Jul 21, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 22.5 -2,071 -2.62% ✗ $137.3K
Jul 14, 2025 Jul 14, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.50% ✓ $26K
Jun 13, 2025 Jun 16, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 51.3 -400 -0.50% ✓ $24.5K
May 22, 2025 May 27, 2025 HAUGHEY THOMAS Director Neutral 85.0 +4,336 8.42% ✗ -
May 22, 2025 May 27, 2025 Leonard Matthew J Director Neutral 90.0 +4,336 36.15% ✗ -
May 22, 2025 May 27, 2025 Pera Antonio R Director Neutral 90.0 +4,336 13.97% ✗ -
May 22, 2025 May 27, 2025 TANNENBAUM RENEE P Director Neutral 90.0 +4,336 19.17% ✗ -
May 22, 2025 May 27, 2025 Thoma Jeanne Director Neutral 90.0 +4,336 10.68% ✗ -
May 22, 2025 May 27, 2025 Walsh Patrick D Director Neutral 85.0 +4,336 5.80% ✗ -
May 15, 2025 May 16, 2025 Gutwerg Ori SVP, GENERICS Sell 32.5 -881 -0.97% ✗ $52.9K
May 14, 2025 May 15, 2025 Mutz Christopher HEAD OF RARE DISEASE Sell 22.5 -4,000 -3.59% ✗ $241.8K
May 13, 2025 May 13, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 52.5 -400 -0.50% ✓ $24.9K
May 9, 2025 May 13, 2025 Shanmugam Muthusamy COO Sell 51.3 -700 -0.10% ✓ $53.8K
Apr 14, 2025 Apr 14, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 52.5 -400 -0.50% ✓ $27.6K
Mar 23, 2025 Mar 25, 2025 Lalwani Nikhil CEO Sell 17.5 -17,455 -3.59% ✗ $1.1M
Mar 23, 2025 Mar 25, 2025 CAREY STEPHEN P. CFO Sell 20.0 -6,210 -3.32% ✗ $399.1K
Mar 19, 2025 Mar 20, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 41.3 -1,866 -2.80% ✓ $121.3K
Mar 13, 2025 Mar 14, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 52.5 -400 -0.49% ✓ $25.3K
Mar 7, 2025 Mar 14, 2025 Mutz Christopher HEAD OF RARE DISEASE Sell 22.5 -2,874 -2.52% ✗ $174.2K
Mar 7, 2025 Mar 14, 2025 Lalwani Nikhil CEO Sell 17.5 -17,060 -3.39% ✗ $1M
Mar 7, 2025 Mar 14, 2025 Gutwerg Ori SVP, GENERICS Sell 22.5 -3,314 -3.52% ✗ $200.9K
Mar 7, 2025 Mar 14, 2025 CAREY STEPHEN P. CFO Sell 20.0 -5,150 -2.68% ✗ $312.2K
Mar 7, 2025 Mar 10, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 45.0 -1,000 -1.48% ✓ $60.9K
Mar 5, 2025 Mar 7, 2025 Gutwerg Ori SVP, GENERICS Sell 20.0 -5,384 -5.41% ✗ $323K
Feb 28, 2025 Mar 4, 2025 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 26.3 -627 -1.36% ✗ $38.8K
Feb 28, 2025 Mar 4, 2025 Mutz Christopher HEAD OF RARE DISEASE Sell 22.5 -1,275 -1.10% ✗ $78.9K
Feb 28, 2025 Mar 4, 2025 Lalwani Nikhil CEO Sell 20.0 -12,216 -2.37% ✗ $756K
Feb 28, 2025 Mar 4, 2025 Gutwerg Ori SVP, GENERICS Sell 22.5 -1,570 -1.56% ✗ $97.2K
Feb 28, 2025 Mar 4, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 22.5 -1,099 -1.60% ✗ $68K
Feb 28, 2025 Mar 4, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 22.5 -1,099 -1.34% ✗ $68K
Feb 28, 2025 Mar 4, 2025 CAREY STEPHEN P. CFO Sell 32.5 -1,861 -0.96% ✗ $115.2K
Feb 21, 2025 Feb 24, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 45.0 -1,000 -1.44% ✓ $60.2K
Feb 12, 2025 Feb 18, 2025 Shanmugam Muthusamy COO Neutral 82.5 +23,936 3.39% ✗ -
Feb 12, 2025 Feb 18, 2025 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS Sell 91.3 +12,474 37.11% ✗ $34.3K
Feb 12, 2025 Feb 18, 2025 Mutz Christopher HEAD OF RARE DISEASE Sell 95.0 +38,689 50.39% ✗ $156.6K
Feb 12, 2025 Feb 18, 2025 Lalwani Nikhil CEO Sell 97.5 +144,532 39.02% ✗ $459.5K
Feb 12, 2025 Feb 18, 2025 Gutwerg Ori SVP, GENERICS Sell 95.0 +23,519 30.45% ✗ $152.8K
Feb 12, 2025 Feb 18, 2025 Gassert Chad SVP - CORP. DEV. & STRATEGY Neutral 85.0 +23,936 9.85% ✗ -
Feb 12, 2025 Feb 18, 2025 Davis Krista SVP, CHIEF HR OFFICER Sell 95.0 +20,565 41.92% ✗ $70.5K
Feb 12, 2025 Feb 18, 2025 Cook Meredith SR. VP, GENERAL COUNSEL & SEC. Sell 95.0 +26,456 47.59% ✓ $108.3K
Feb 12, 2025 Feb 18, 2025 CAREY STEPHEN P. CFO Sell 95.0 +39,616 25.65% ✗ $101.9K